NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

Here is another connection between NWBio and ATL-DC:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568250/#!po=1.42857

This study compared autologous tumor lysate (ATL) loading of dendritic cells (DC), with dendritic cells loaded with synthetic glioma-associated antigen (GAA) peptides, in malignant glioma patients.

Look down at the acknowledgments at the bottom of the page. This study was funded in part by the National Institutes of Health (NIH), the National Cancer Institute (NCI) and Northwest Biotherapeutics. This study concluded that ATL-DC (DCVax-L) vaccination may induce a more heterogeneous and diverse anti-tumor immune response against malignant glioma.

ATL-DC is the version of DCVax-L that is made on site at UCLA. It is not the branded version.that is made by Cognate or Advent Bioservices.